MeiraGTx Holdings (MGTX) Enterprise Value Growth (3y) (2020 - 2025)
MeiraGTx Holdings (MGTX) Enterprise Value Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.05% |
| Sep 30, 2025 | 49.42% |
| Jun 30, 2025 | 23.59% |
| Mar 31, 2025 | 16.38% |
| Dec 31, 2024 | 9.03% |
| Sep 30, 2024 | 4.52% |
| Jun 30, 2024 | 16.34% |
| Mar 31, 2024 | 15.51% |
| Dec 31, 2023 | 14.57% |
| Sep 30, 2023 | 28.95% |
| Jun 30, 2023 | 21.91% |
| Mar 31, 2023 | 31.19% |
| Dec 31, 2022 | 20.19% |
| Sep 30, 2022 | 23.22% |
| Jun 30, 2022 | 29.34% |
| Mar 31, 2022 | 20.61% |
| Dec 31, 2021 | -26.39% |
| Sep 30, 2021 | -17.49% |
| Jun 30, 2021 | -19.08% |
| Mar 31, 2021 | -83.11% |